-6.4 C
New York
Monday, February 9, 2026

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles